Related references
Note: Only part of the references are listed.BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
A. Laroche-Clary et al.
BRITISH JOURNAL OF CANCER (2015)
Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity
Kirsten Lauber et al.
CANCER LETTERS (2015)
Biodosimetry Based on γ-H2AX Quantification and Cytogenetics after Partial- and Total-Body Irradiation during Fractionated Radiotherapy
Sebastian Zahnreich et al.
RADIATION RESEARCH (2015)
Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II study
S. Delaloge et al.
ANNALS OF ONCOLOGY (2014)
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali et al.
ANNALS OF ONCOLOGY (2014)
Hyperthermia Induces Apoptosis through Endoplasmic Reticulum and Reactive Oxygen Species in Human Osteosarcoma Cells
Chun-Han Hou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis
Mateusz Rytelewski et al.
MOLECULAR ONCOLOGY (2014)
Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study
B. L. Samuels et al.
ANNALS OF ONCOLOGY (2013)
Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma
Hege O. Ohnstad et al.
CANCER (2013)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations
S. Bayraktar et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Hyperthermia inhibits homologous recombination repair and sensitizes cells to ionizing radiation in a time- and temperature-dependent manner
Stefan C. Genet et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Senescence and aging: the critical roles of p53
A. Rufini et al.
ONCOGENE (2013)
γ-H2AX and other histone post-translational modifications in the clinic
Christophe E. Redon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2012)
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
P. M. L. H. Vencken et al.
ANNALS OF ONCOLOGY (2011)
ERCC5/XPG, ERCC1, and BRCA1 Gene Status and Clinical Benefit of Trabectedin in Patients With Soft Tissue Sarcoma
Antoine Italiano et al.
CANCER (2011)
Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
P. Schoffski et al.
EUROPEAN JOURNAL OF CANCER (2011)
Homologous recombination research is heating up and ready for therapy
Simon N. Powell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition
Przemek M. Krawczyk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Quality Assurance for Clinical Studies in Regional Deep Hyperthermia
Gregor Bruggmoser et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2011)
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Giovanni Germano et al.
CANCER RESEARCH (2010)
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
Maurizio D'Incalci et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
Rolf D. Issels et al.
LANCET ONCOLOGY (2010)
Purified human BRCA2 stimulates RAD51-mediated recombination
Ryan B. Jensen et al.
NATURE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Shirley M. H. Sy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
In vitro radiosensitisation by trabectedin in human cancer cell lines
Jesus Romero et al.
EUROPEAN JOURNAL OF CANCER (2008)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Extreme sensitivity to Yondelis® (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53
Victoria Moneo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin
Ana B. Herrero et al.
CANCER RESEARCH (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Quantitative assay of senescence-associated β-galactosidase activity in mammalian cell extracts
RK Gary et al.
ANALYTICAL BIOCHEMISTRY (2005)
Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production
P Allavena et al.
CANCER RESEARCH (2005)
Effects of a heat shock protein inhibitor KNK437 on heat sensitivity and heat tolerance in human squamous cell carcinoma cell lines differing in p53 status
K Ohnishi et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2004)
In vitro interaction between Ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects
C Simoens et al.
BRITISH JOURNAL OF CANCER (2003)
Role of BRCA1 in heat shock response
YX Ma et al.
ONCOGENE (2003)
The cellular and molecular basis of hyperthermia
B Hildebrandt et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
ATM phosphorylates histone H2AX in response to DNA double-strand breaks
S Burma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Role of BRCA2 in control of the RAD51 recombination and DNA repair protein
AA Davies et al.
MOLECULAR CELL (2001)
Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743
M Minuzzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)